
(Reuters) – Oxford scientists are preparing to rapidly produce new versions of their vaccine to combat emerging COVID-19 variants from the UK, South Africa and Brazil, The Telegraph reported on Wednesday.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.